BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 8818331)

  • 1. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
    Roccon A; Marchionni D; Nisato D
    Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
    Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
    Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system.
    Couture R; Laneuville O; Guimond C; Drapeau G; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):547-57. PubMed ID: 2482449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
    Picard P; Chrétien L; Couture R
    Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
    Giuliani S; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):512-9. PubMed ID: 8751080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.
    Medhurst AD; Parsons AA; Roberts JC; Hay DW
    Br J Pharmacol; 1997 Jan; 120(1):93-101. PubMed ID: 9117105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig.
    Daoui S; Naline E; Lagente V; Emonds-Alt X; Advenier C
    Br J Pharmacol; 2000 May; 130(1):49-56. PubMed ID: 10780997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation.
    Couture R; Picard P; Poulat P; Prat A
    Can J Physiol Pharmacol; 1995 Jul; 73(7):892-902. PubMed ID: 8846427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
    Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
    Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.
    Yuan YD; Couture R
    Br J Pharmacol; 1997 Mar; 120(5):785-96. PubMed ID: 9138683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists.
    Mazzone SB; Geraghty DP
    Br J Pharmacol; 2000 Mar; 129(6):1121-31. PubMed ID: 10725260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.
    Foulon DM; Champion E; Masson P; Rodger IW; Jones TR
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):915-21. PubMed ID: 7692776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular pathways mediating tachykinin-evoked secretomotor responses in guinea pig ileum.
    MacNaughton W; Moore B; Vanner S
    Am J Physiol; 1997 Nov; 273(5):G1127-34. PubMed ID: 9374711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary permeability induced by intravenous neurokinins. Receptor characterization and mechanism of action.
    Jacques L; Couture R; Drapeau G; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):170-9. PubMed ID: 2478892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin receptors in the guinea-pig isolated oesophagus: a complex system.
    Kerr KP; Mitchelson F; Coupar IM
    Br J Pharmacol; 1997 Mar; 120(6):1021-8. PubMed ID: 9134212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.